130 related articles for article (PubMed ID: 36326016)
1. Iris melanoma outcomes based on the Cancer Genome Atlas (TCGA) classification in 78 consecutive patients.
Cherkas E; Negretti GS; Zeiger JS; Shields CL
Ophthalmic Genet; 2022 Dec; 43(6):736-741. PubMed ID: 36326016
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Fitzpatrick Skin Type and The Cancer Genome Atlas Classification with Melanoma-Related Metastasis and Death in 854 Patients at a Single Ocular Oncology Center.
Sen M; Card KR; Caudill GB; Spitofsky NR; Dockery PW; Zaloga AR; Zeiger JS; DeYoung CF; Hamou SJ; Shields CL
Ophthalmic Genet; 2022 Dec; 43(6):742-755. PubMed ID: 36369870
[TBL] [Abstract][Full Text] [Related]
3. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA
Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428
[TBL] [Abstract][Full Text] [Related]
4. Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D.
Vichitvejpaisal P; Dalvin LA; Mazloumi M; Ewens KG; Ganguly A; Shields CL
Ophthalmology; 2019 Oct; 126(10):1445-1453. PubMed ID: 31026493
[TBL] [Abstract][Full Text] [Related]
5. Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
Shields CL; Mayro EL; Bas Z; Dockery PW; Yaghy A; Lally SE; Ganguly A; Shields JA
Indian J Ophthalmol; 2021 Jul; 69(7):1839-1845. PubMed ID: 34146040
[TBL] [Abstract][Full Text] [Related]
6. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.
Mazloumi M; Vichitvejpaisal P; Dalvin LA; Yaghy A; Ewens KG; Ganguly A; Shields CL
JAMA Ophthalmol; 2020 Mar; 138(3):260-267. PubMed ID: 31944225
[TBL] [Abstract][Full Text] [Related]
8. Iris melanoma: features and prognosis in 317 children and adults.
Shields CL; Kaliki S; Shah SU; Luo W; Furuta M; Shields JA
J AAPOS; 2012 Feb; 16(1):10-6. PubMed ID: 22370659
[TBL] [Abstract][Full Text] [Related]
9. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
[TBL] [Abstract][Full Text] [Related]
10. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
Gollrad J; Böker A; Vitzthum S; Besserer A; Heufelder J; Gauger U; Böhmer D; Budach V; Zeitz O; Joussen AM
Ophthalmol Retina; 2023 Mar; 7(3):266-274. PubMed ID: 36087876
[TBL] [Abstract][Full Text] [Related]
11. Iris melanoma: factors predictive of post-management secondary glaucoma in 271 cases at a Single Ocular Oncology Centre.
Shukla AG; Vaidya S; Yaghy A; Di Nicola M; Kaliki S; Fulco E; Myers JS; Shields JA; Shields CL
Eye (Lond); 2023 Apr; 37(5):938-946. PubMed ID: 35383310
[TBL] [Abstract][Full Text] [Related]
12. Correlation of fitzpatrick skin type and iris color with tumor size in 823 patients with uveal melanoma.
Agrawal KU; Barke MR; Chiang L; Ni R; Kim RS; Zhang Q; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100046. PubMed ID: 38320655
[TBL] [Abstract][Full Text] [Related]
13. Association of Fitzpatrick Skin Type with metastatic risk from uveal melanoma in 854 consecutive patients at a single center.
Negretti GS; Bayasi F; Goldstein S; Omega M; Taylor O; Ni R; Chiang L; Kim R; Lien E; Barke M; Dockery PW; Shields CL
Eye (Lond); 2024 Feb; 38(3):565-571. PubMed ID: 37770529
[TBL] [Abstract][Full Text] [Related]
14. Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma.
Eibenberger K; Heimann H; Gatchalian L; Kacperek A; Hussain R
Ophthalmology; 2023 Sep; 130(9):958-965. PubMed ID: 37169262
[TBL] [Abstract][Full Text] [Related]
15. Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas.
Krishna Y; Kalirai H; Thornton S; Damato BE; Heimann H; Coupland SE
Br J Ophthalmol; 2016 Jul; 100(7):1012-1016. PubMed ID: 27098748
[TBL] [Abstract][Full Text] [Related]
16. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
[TBL] [Abstract][Full Text] [Related]
17. Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide.
Shields CL; Kaliki S; Hutchinson A; Nickerson S; Patel J; Kancherla S; Peshtani A; Nakhoda S; Kocher K; Kolbus E; Jacobs E; Garoon R; Walker B; Rogers B; Shields JA
Ophthalmology; 2013 Apr; 120(4):766-72. PubMed ID: 23290981
[TBL] [Abstract][Full Text] [Related]
18. Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal Melanoma.
Gelmi MC; Bas Z; Malkani K; Ganguly A; Shields CL; Jager MJ
Ophthalmology; 2022 Apr; 129(4):431-437. PubMed ID: 34793831
[TBL] [Abstract][Full Text] [Related]
19. Diffuse iris melanoma: a report of 25 cases.
Demirci H; Shields CL; Shields JA; Eagle RC; Honavar SG
Ophthalmology; 2002 Aug; 109(8):1553-60. PubMed ID: 12153810
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
